Actinogen Medical Limited (ASX:ACW) has notified the ASX of the cancellation of 4,400,000 ordinary fully paid shares on 12 November 2026, pursuant to an employee share scheme buy-back, according to an Appendix 3H filing lodged on the same date.

Key Points

  • 4,400,000 ACW ordinary fully paid shares ceased on 12 November 2026 via cancellation pursuant to an employee share scheme buy-back
  • No consideration was paid by the entity for the cessation of the securities
  • Following the cancellation, ACW ordinary fully paid shares on issue total 3,869,768,325
  • Quoted options on issue comprise 277,249,773 options expiring 30 September 2027 and 175,436,237 options expiring 31 May 2027

Cessation of Ordinary Shares Under Employee Share Scheme Buy-Back

Actinogen Medical Limited disclosed the cessation of 4,400,000 ordinary fully paid securities under ASX code ACW, with the date of cessation recorded as 12 November 2026. The filing states the reason for cessation was cancellation pursuant to an employee share scheme buy-back. The company confirmed that no consideration was paid by the entity in connection with the cessation of these securities. The notification was submitted to the ASX as a new announcement on 12 November 2026 using the Appendix 3H form for notification of cessation of securities.

Issued Capital Following the Cancellation

Following the cessation of the 4,400,000 ordinary fully paid shares, Actinogen Medical's total quoted ordinary fully paid securities on issue stand at 3,869,768,325. In addition, the company has two classes of quoted options remaining on issue: 277,249,773 options expiring 30 September 2027 under the code ACWOC, and 175,436,237 options expiring 31 May 2027 under the code ACWOD. The filing notes that the figures disclosed in the issued capital table are automatically generated and may not reflect current issued capital if other forms are simultaneously being processed by ASX.

Filing and Entity Details

The notification was filed by Actinogen Medical Limited, registered under Australian Company Number 086778476 and listed on the ASX under the issuer code ACW. The Appendix 3H form was submitted as a new announcement dated 12 November 2026. The filing did not include any additional information beyond the details of the cessation and the resulting issued capital figures. No unquoted equity securities were listed in the issued capital table accompanying the notification.